Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weiqida
- Development stage
- Unknown
- Lead developer
- Sinopharm Weiqida Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral, Intravenous, Intramuscular
01
Overview
Weiqida (威奇达) is a prominent brand name and the name of a key subsidiary (Datong Weiqida Pharmaceutical) of Shanghai Shyndec Pharmaceutical, which is part of the Sinopharm Group. The brand represents a comprehensive portfolio of anti-infective pharmaceutical products, with a particular emphasis on beta-lactam antibiotics. This portfolio includes a wide range of penicillins and cephalosporins, such as amoxicillin, amoxicillin/clavulanate potassium, and ceftriaxone. Datong Weiqida is a vertically integrated manufacturer, producing pharmaceutical intermediates (such as 6-APA and 7-ACA), active pharmaceutical ingredients (APIs), and finished dosage forms. The products marketed under the Weiqida brand are approved for the treatment of various bacterial infections and are known for their role in inhibiting bacterial cell wall synthesis.
- Brand names
- 威奇达Weiqida
- Other names
- Datong Weiqida
02
Targets
PBP (Penicillin-binding protein family)β-lactamase
Beyond the preview
Go deeper on Weiqida.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weiqida.